The upcoming Brilacidin phase 3 trial is only expected to cost $6mil. The FDA may require them to do two. If so, the cost will be a total of $12mil.
The U of Bologna is covering the cost of the Kevetrin trial they are doing.
MDA is covering the cost of the work they are doing.
I'm at my daughter's house and not at my computer and don't have the data handy. But, these trials aren't costing as much as you seem to think. What isn't covered will end up being picked up by use of the shelf they have.
In Reply to 'georgejjl'
Thiese are the questions that needs to be answered SOON.
How and where will Cellceutix get the money to fund all of the proposed new trials?
These could be very big Phase III trials.
Could it be that there are ongoing negotiations to answer the question above about how and from where the money will come?
Good luck and GOD bless,
George
News 
Market Data 
Discover 
